Idexx Laboratories Inc (IDXX)
Health Care – IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
- Headquarters
- United States
- Employees
- 11,000
- Market Cap
- $44.9B
About Idexx Laboratories Inc
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
SentiSense also tracks daily options readings for Idexx Laboratories Inc: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Idexx Laboratories Inc stock analysis, sentiment tracking, and market intelligence on SentiSense.